Precision Medical Testing Lab Registration Guidelines Abolished
Summary
The Taiwan Food and Drug Administration (TFDA) has abolished the 'Key Points for Registration Management of Precision Medical Molecular Testing Laboratories' (精準醫療分子檢測實驗室列冊登錄管理要點), with effect from 21 April 2026. This eliminates the registration and management framework that governed precision medical molecular testing laboratories under the Quality Supervision and Management Division. Affected laboratories previously subject to these guidelines should verify whether alternative regulatory requirements remain applicable.
Precision medical molecular testing laboratories that were operating under the abolished guidelines should conduct a compliance review to determine whether their facilities remain subject to any remaining TFDA requirements, including quality management or laboratory certification standards. Where registration was a prerequisite for reimbursement, billing, or regulatory clearance, the loss of that status should be flagged to legal and regulatory affairs teams immediately.
About this source
GovPing monitors TFDA Taiwan News for new consumer protection regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 3 changes logged to date.
What changed
TFDA Taiwan has formally abolished the administrative guidelines governing the registration and management of precision medical molecular testing laboratories, eliminating the compliance framework these facilities were required to follow. The abolition takes effect on 21 April 2026 under Order No. FDA品字第1151101125號. Laboratories that were previously registered or required to register under these guidelines should confirm whether alternative regulatory obligations remain in place, as the abolition may affect their ongoing compliance status under Taiwan's medical device and laboratory regulations.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
公告資訊
- 本署公告
- 本署新聞
- 維護公告
- 活動訊息
- 預告法規沿革區
- 食藥膨風廣告專區
- 食藥闢謠專區
- 國內衛生局新聞
- 國外消費紅綠燈
- 本署徵才
- 重大政策
- 科技計畫
- 招標資訊
- 新聞API服務
- 國際與兩岸會議及研討會 目前位置： 首頁 > 公告資訊 > 本署公告 ### 廢止「精準醫療分子檢測實驗室列冊登錄管理要點」 | 發布日期：2026-04-21 | 維護日期：2026-04-21 發布單位：品質監督管理組
廢止「精準醫療分子檢測實驗室列冊登錄管理要點」，並自即日生效。
檔案下載
- 115年4月21日FDA品字第1151101125號令
資訊內容對您是否有幫助：
| 極其有幫助 | 非常有幫助 | 有一定幫助 | 有點幫助 | 沒有幫助 |
驗證碼： 回上一頁
Named provisions
Related changes
Get daily alerts for TFDA Taiwan News
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from TFDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when TFDA Taiwan News publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.